Dear Friends and Colleagues,
Welcome back to the Reach Separations newsletter, we've been away for a while (how is it October already?!) but are looking forward to updating you with our goings on each quarter. You can expect an update on where we've been: this year has seen us attend our first conference on the West Coast of America. Where you're likely to catch us next, and of course, an update from the lab. As the title suggests, this year has seen a huge increase in achiral separations here at Reach, so please keep reading to find out more.
As for 2019 so far, we travelled to California in April, to meet new clients and to attend the Drug Discovery conference in San Diego. We were in Nantes for RICT2019 and Milan for HPLC. We've seen our European and UK client base grow and as such have made plenty of changes here at HQ. We now have a dedicated scientist who resides in our QC lab, ensuring all returned samples are of the highest quality. Daniel Von Emloh is now our official QC analyst, please join us in congratulating Dan on his new role.
As always, if you have any questions or comments drop me a note, Victoria Coulthard, (firstname.lastname@example.org)
, Business Development Manager.